FAM162A and dilated cardiomyopathy: Consistent with the mouse data, an increased expression of FAM162A was observed in human dilated cardiomyopathy (DCM), idiopathic cardiomyopathy, and ischemic cardiomyopathy (ICM), albeit not significantly.